Lack of Association between Tumor Necrosis Factor-alpha -308 G/A Polymorphism and Risk of Developing Late-Onset Alzheimer's Disease in an Iranian Population
- PMID: 23408162
- PMCID: PMC3558134
Lack of Association between Tumor Necrosis Factor-alpha -308 G/A Polymorphism and Risk of Developing Late-Onset Alzheimer's Disease in an Iranian Population
Abstract
Late-onset Alzheimer's Disease (LOAD) is a neurodegenerative disorder and the most common form of dementia affecting people over 65 years old. Alzheimer's disease is a complex disease with multi-factorial etiology. Inflammation has been approved to have an important role in the pathogenesis of Alzheimer's disease (AD). TNF-α is a main pro-inflammatory cytokine that plays an essential role in initiation and regulation of inflammatory responses. Several studies have shown the probable association of polymorphism at TNF-α gene's promoter with AD pathogenesis. This study was performed to determine whether this polymorphism contributes to the risk for late-onset Alzheimer's disease (LOAD) in Iranian population. One hundred and forty AD patients and 158 healthy controls were recruited in the study. Following extraction of genomic DNA, using PCR/RFLP methods the genotype and allele frequencies were determined in case and control subjects. The statistical analysis showed no significant difference in the allele and genotype frequencies due to this polymorphism between the two groups. Also after stratifying the subjects by their APOE-ɛ4 status, no significant association was observed. Our results suggest that Tumor necrosis factor-alpha (TNF-α)-308 G/A is not a risk or protective factor for late-onset Alzheimer's disease in Iranian population. However, to confirm these results further study with a bigger sample size may be required.
Keywords: Alzheimer's disease; Gene; Genetic association study; Polymorphism; Population; TNF-α.
Similar articles
-
Association of CALHM1 Gene Polymorphism with Late Onset Alzheimer's Disease in Iranian Population.Avicenna J Med Biotechnol. 2010 Jul;2(3):153-7. Avicenna J Med Biotechnol. 2010. PMID: 23408664 Free PMC article.
-
Genetic association of TNF-α-308 G/A and -863 C/A polymorphisms with late onset Alzheimer's disease in Azeri Turk population of Iran.J Res Med Sci. 2011 Aug;16(8):1006-13. J Res Med Sci. 2011. PMID: 22279475 Free PMC article.
-
Genetic analysis of tumor necrosis factor-alpha (TNF-alpha) G-308A and Saitohin Q7R polymorphisms with Alzheimer's disease.J Neurol Sci. 2008 Jul 15;270(1-2):148-51. doi: 10.1016/j.jns.2008.02.021. Epub 2008 Apr 8. J Neurol Sci. 2008. PMID: 18396294
-
Interleukin 6-174 G/C promoter gene polymorphism and sporadic Alzheimer's disease: geographic allele and genotype variations in Europe.Exp Gerontol. 2004 Oct;39(10):1567-73. doi: 10.1016/j.exger.2004.07.006. Exp Gerontol. 2004. PMID: 15501028 Review.
-
Association between Apolipoprotein E Gene Polymorphism and Alzheimer's Disease in an Iranian Population: A Meta-Analysis.J Mol Neurosci. 2019 Dec;69(4):557-562. doi: 10.1007/s12031-019-01381-1. Epub 2019 Aug 23. J Mol Neurosci. 2019. PMID: 31444704 Review.
Cited by
-
Inflammatory Cytokines and Alzheimer's Disease: A Review from the Perspective of Genetic Polymorphisms.Neurosci Bull. 2016 Oct;32(5):469-80. doi: 10.1007/s12264-016-0055-4. Epub 2016 Aug 27. Neurosci Bull. 2016. PMID: 27568024 Free PMC article. Review.
-
Synergistic influence of cytokine gene polymorphisms over the risk of dementia: A multifactor dimensionality reduction analysis.Front Aging Neurosci. 2022 Oct 26;14:952173. doi: 10.3389/fnagi.2022.952173. eCollection 2022. Front Aging Neurosci. 2022. PMID: 36389080 Free PMC article.
-
An Association Study on IL16 Gene Polymorphisms with the Risk of Sporadic Alzheimer's Disease.Avicenna J Med Biotechnol. 2015 Jul-Sep;7(3):128-32. Avicenna J Med Biotechnol. 2015. PMID: 26306153 Free PMC article.
-
Association between TNF-α promoter -308 A/G polymorphism and Alzheimer's disease: a meta-analysis.Neurol Sci. 2015 Jun;36(6):825-32. doi: 10.1007/s10072-015-2102-8. Epub 2015 Feb 3. Neurol Sci. 2015. PMID: 25647294
References
-
- Tuppo EE, Arias HR. The role of inflammation in Alzheimer's disease. Int J Biochem Cell Biol. 2005;37(2):289–305. - PubMed
-
- McGeer PL, McGeer EG. NSAIDs and Alzheimer disease: Epidemiological, animal model and clinical studies. Neurobiol Aging. 2007;28(5):639–647. - PubMed
-
- Streit WJ, Kincaid-Colton CA. The brain's im-mune system. Sci Am. 1995;273(5):54–61. - PubMed
-
- Rogers J, Lue LF. Microglial chemotaxis, activation, and phagocytosis of amyloid beta-peptide as linked phenomena in Alzheimer's disease. Neurochem Int. 2001;39(5-6):333–340. - PubMed
-
- Perry RT, Collins JS, Wiener H, Acton R, Go RC. The role of TNF and its receptors in Alzheimer's disease. Neurobiol Aging. 2001;22(6):873–883. - PubMed
LinkOut - more resources
Full Text Sources
Miscellaneous